Synomis, Inc. — SEC Form D Filing
Synomis, Inc. filed an SEC Form D on October 30, 2026, reporting $30K raised in Biotechnology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- October 30, 2026
- Amount reported
- $30K
- Round stage
- Pre-seed, given the small initial capital raise of $30,000 to cover early entity formation and initial proof-of-concept work.
- Industry
- Biotechnology
- Website
- https://www.synomis.com
What the company does
Exemption: Rule 506(b). Incorporated: TENNESSEE
Problem
Complex biological targets require novel targeted therapeutic platforms to address high unmet medical needs in patient populations.
Solution
Synomis develops novel biopharmaceutical therapeutics and early-stage biotechnology solutions to treat complex human diseases.
Why now
Recent advancements in genomic sequencing and molecular biology allow early-stage biotechnology startups to validate scientific hypotheses with minimal initial seed capital.
Source: SEC EDGAR Form D filing